Vigilancia Tecnológica

This paper explores polymeric nanosystems (PN) as a solution to challenges with traditional anti?inflammatory drugs (AID). PN offer improved biocompatibility, low toxicity, and targeted AID delivery. It reviews three PN classes, detailing their properties, preparation methods, and applications in treating inflammation and inflammation related diseases, highlighting their expanding role in clinical practice.ABSTRACTInflammation processes can cause mild to severe damage in the human body and can lead to a large number of inflammation?related diseases (IRD) such as cancer, neural, vascular, and pulmonary diseases. Limitations of anti?inflammatory drugs (AID) application are reflected in high therapeutic doses, toxicity, low bioavailability and solubility, side effects, etc. Polymeric nanosystems (PS) have been recognized as a safe and effective technology that is able to overcome these limitations by AID encapsulation and is able to answer to the specific demands of the IRD treatment. PS are attracting great attention due to their versatility, biocompatibility, low toxicity, fine?tuned properties, functionality, and ability for precise delivery of anti?inflammatory drugs to the targeted sites in the human body. This article offers an overview of three classes of polymeric nanosystems: a) dendrimers, b) polymeric micelles and polymeric nanoparticles, and c) polymeric filomicelles, as well as their properties, preparation, and application in IRD treatment. In the future, the number of PS formulations in clinical practice will certainly increase.